Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,797 | 1,368 | 3,849 | 3,517 | 5,181 |
| Marketable Securities | 2,000 | 3,826 | 3,826 | 858 | 1,456 |
| Receivables | 2,560 | 1,633 | 1,031 | 1,141 | 1,189 |
| Inventories | 2,055 | 2,181 | 2,127 | 1,444 | 1,501 |
| Other current assets | 1,527 | 428 | 444 | 188 | 391 |
| TOTAL | $9,938 | $9,436 | $11,276 | $7,148 | $9,718 |
| Non-Current Assets | |||||
| PPE Net | 4,456 | 5,314 | 5,431 | 5,384 | 5,274 |
| Intangibles | 94 | 94 | 94 | 0 | 0 |
| Other Non-Current Assets | 1,482 | 1,498 | 1,568 | 2,581 | 2,568 |
| TOTAL | $6,033 | $6,906 | $7,094 | $7,965 | $7,842 |
| Total Assets | $15,970 | $16,341 | $18,370 | $15,112 | $17,559 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,000 | 1,000 | 1,000 | 280 | 276 |
| Accounts payable and accrued liabilities | 1,597 | 1,485 | 1,279 | 875 | 871 |
| Accrued Expenses | 513 | 692 | 461 | 678 | 475 |
| TOTAL | $4,385 | $3,570 | $3,245 | $2,516 | $2,478 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,417 | 1,667 | 2,000 | 1,086 | 1,157 |
| Deferred Revenues | 104 | 106 | 121 | 113 | 70 |
| Other Non-Current Liabilities | 0 | 0 | 371 | 0 | 0 |
| TOTAL | $2,157 | $2,423 | $2,790 | $1,358 | $1,708 |
| Total Liabilities | $6,542 | $5,993 | $6,035 | $3,875 | $4,185 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,852 | 13,742 | 13,742 | 13,667 | 13,640 |
| Common Shares | 110,303 | 109,937 | 109,908 | 108,617 | 108,580 |
| Retained earnings | -102,753 | -101,467 | -99,451 | -97,380 | -95,206 |
| Other shareholders' equity | 1,879 | 1,879 | 1,879 | 0 | 0 |
| TOTAL | $9,428 | $10,348 | $12,335 | $11,238 | $13,374 |
| Total Liabilities And Equity | $15,970 | $16,342 | $18,370 | $15,112 | $17,559 |